| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10970215 | Vaccine | 2010 | 6 Pages |
Abstract
Increased serotype coverage of the 13-valent vaccine is expected to have a substantial public health and economic impact on infectious disease, when considering direct and indirect effects.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Anderson W. Chuck, Philip Jacobs, Gregory Tyrrell, James D. Kellner,